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Abstract
Background: Tuberculosis (TB) remains a global health challenge and depression is a significant contributor to the
global burden of disease. Current evidence suggests that there is an association between depressive symptoms and
TB, lower adherence to treatment, and increased morbidity and mortality. However, there is paucity of data regarding
these associations in Cameroon. This study aimed to determine the prevalence and correlates of depression in adult
patients with pulmonary TB (PTB) in the Southwest Region of Cameroon.
Methods: A hospital-based cross-sectional study involving 265 patients with PTB was conducted from 2nd January to
31st March 2015 in the Limbe Regional Hospital and the Kumba District Hospital. Depression was diagnosed using the
standard nine-item Patient Health Questionnaire, and classified as none, mild or moderate. Logistic regressions were
used to investigate correlates of depression in these patients.
Results: Of the 265 patients (mean age 36.9 ± 10 years) studied, 136 (51.3 %) were female. The prevalence of
depression was 61.1 % (95 % CI: 55.1–66.8), with a significant proportion (36.6 %) having mild depression.
Multivariable logistic regression analysis showed that being female (aOR = 3.0, 95 % CI (1.7–5.5), P < 0.001),
having a family history of mental illness (aOR = 2.5, 95 % CI: 1.3–5.4, P > 0.05), being on retreatment for TB
(aOR = 11.2, 95 % CI: 5.2–31.1, P < 0.001), having discontinued treatment (aOR = 8.2, 95 % CI: 1.1–23.3, P < 0.05)
and having a HIV/TB co-infection (aOR = 2.5, 95 % CI: 1.2–6.5, P < 0.001) were factors associated with having a
higher chance of being depressed.
Conclusion: Our study suggests that there is a high prevalence of depression among PTB patients, with more
than one in two patients affected. Multidisciplinary care for TB patients involving mental health practitioners is
highly encouraged, especially for high-risk groups.
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Background
Tuberculosis (TB) remains a leading infectious cause of
morbidity and mortality worldwide. The recent 2013
global incidence of TB is nine million, with more than
half (56 %) of those infected residing in Southeast Asia
and the Western Pacific regions. A further quarter is in
the African region, which also had high prevalence and
mortality rates [1]. There has been a slow but steady
decrease in the incidence of TB in Cameroon from 260
per 100 000 people in 2010 to 235 per 100 000 as of
2014 [2].
Anxiety disorders and depression are the most preva-
lent mental disorders in the general population. Depres-
sion is a common mental disorder characterised by loss
of interest or pleasure, feelings of guilt or low self-worth,
disturbed sleep or appetite, low energy and poor concen-
tration, insomnia or hypersomnia and occasionally sui-
cidal thoughts [3, 4]. Depression affects 350 million
people globally and a health survey conducted by the
World Health Organization (WHO) in 2012, in 17 coun-
tries revealed that one in 20 people reported depression
[3]. According to a WHO report on global burden of
disease (GBD) in 2008, depression ranks fourth and is
predicted that, by 2030 it might be the leading burden of
disease worldwide [5]. Depression can lead to suicide,
which accounts for the loss of one million lives per year
and 30,000 deaths/day globally [3, 6].
The prevalence of depression in TB patients is re-
ported to be very high, reaching as high as 95.5 % in
Nigeria [7]. Data on the magnitude of depression in TB
patients in Cameroon are scarce, however, a study con-
ducted in Yaoundé by Balkissou et al. reported a 30.9 %
prevalence of depression in TB patients [8]. Further-
more, another study in Yaoundé showed a high preva-
lence of depressive symptoms (63 %) in patients infected
with HIV, a disease commonly associated with TB [9].
Depression has also been identified as a co-morbid
condition in TB and is associated with antibiotic drug
resistance, high rates of community transmission [9, 10],
and an increased level of morbidity and mortality [10,
11]. Depressed individuals with TB are less likely to seek
care promptly and those who do are significantly less
likely to take medications consistently and/or completely
[10–12]. This can lead to drug resistance, morbidity and
mortality [13–16]. Therefore, depression may be an un-
identified driver of TB and multidrug resistant TB epi-
demics. Understanding the relationship between
depression, TB and disease outcomes is crucial for devel-
oping efficient strategies to tackle the persistent burden
of TB, especially in endemic communities. This study
was conducted to determine the prevalence and factors
associated with depression in patients with pulmonary
tuberculosis (PTB) in the Southwest Region of
Cameroon.
Methods
Study design and sites
This was a hospital-based cross-sectional study, con-
ducted from 2nd January to 31st March 2015 with PTB
patients in the Limbe Regional Hospital and the Kumba
District Hospital, two referral hospitals for TB treatment
in the Southwest Region of Cameroon. These hospitals
are well equipped for the diagnosis, management and
follow-up of patients with TB, and offer Directly
Observed Treatment Short course (DOTS) services.
Study participants
The study participants were selected from all patients di-
agnosed with PTB according to the National Tubercu-
losis Control Programme guidelines in Cameroon.
Newly diagnosed PTB patients or those undergoing
retreatment for at least two weeks were included in the
study. Patients with extra-PTB, those aged < 21 years, or
who were pregnant, critically ill or presenting severe
complications such as respiratory distress or a mental ill-
ness (like Alzheimer’s disease) that could impair memory
were excluded.
Sample size and sampling
A convenient sampling method was employed. All pa-
tients who met the inclusion criteria and were receiving
care at the study sites who consented to participate in
the study were considered. Out of the 280 patients who
received care in these hospitals during the study period,
265 were included in the study.
Data collection
Data were collected by two physicians (JK and CJE),
who were assisted by nurses working in the TB units of
the respective study hospitals. Patients with PTB were
interviewed using a structured questionnaire containing
questions on the socio-demographic and disease charac-
teristics of the participants. Socio-demographic variables
included: age, sex, marital status, educational level, place
of residence, employment status and occupation. Disease
specific characteristics included: sputum type, patient
status (hospitalised or outpatient), method of treatment,
presence of an associated co-morbidity and HIV status.
Depression was assessed using the nine-item Patient
Health Questionnaire (PHQ-9), which was administered
in English. The PHQ-9 is a validated tool for the assess-
ment of depression in clinical practice, based on the cri-
teria outlined in the Diagnostic and Statistical Manual of
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Mental Disorders, 4th edition [17, 18]. It has good psy-
chometric properties compared to other validated in-
struments and has been widely used in clinical practice
and research. It has a sensitivity and specificity of 88 %
for major depression [19], and a cut-off score on a scale
of 10 is diagnostic of major depression [20]. It requires
participants to rate, how often and for how long they
have been bothered by any of the listed problems during
the previous two weeks. The score for each question var-
ies from 0 to 3 (0 = not at all, 1 = several days, 2 =more
than half of the days, 3 = nearly every day), with a result
range of 0–27. A score of 0–4 indicates ‘no depression’,
5–9 indicates ‘mild depression’, 10–14 indicates ‘moder-
ate depression’, 15–19 indicates ‘moderately severe de-
pression’ and 20–27 indicates ‘severe depression’. This
was re-categorised as follows: no depression (score 0–4),
mild depression (score 5–14) and moderate depression
(score 15–27). This was adapted from studies by Basu et
al. [21], Issa et al. [22] and Masumoto et al. [23].
Data management and analysis
The data collected were cross checked at the end of
every week, entered into and analysed using IBM SPSS
statistical software v.16 for Windows (SPSS Inc., Chi-
cago, IL, USA). The prevalence of depression in PTB pa-
tients was calculated as a proportion of PTB patients
with a score greater than 4 (on the PHQ-9) out of the
total number of PTB patients.
We summarised continuous variables using means and
standard deviations (SDs), and categorical variables
using frequencies and percentages. The chi-square test
was conducted to determine the associations between
potential predictor variables and depression. A multivar-
iable logistic regression analysis was conducted to inves-
tigate factors independently associated with depression.
A P-value < 0.05 was considered statistically significant.
Ethical consideration
Ethical clearance was obtained from the Faculty of
Health Sciences Institutional Review Board of the
University of Buea, Cameroon. The administrators of the
study hospitals also authorised the study. Written in-
formed consent was obtained from all the participants.
Patient confidentiality was maintained and the study ad-
hered to the Declaration of Helsinki. Patients with mod-
erate to severe depression were referred to a psychiatrist
for further evaluation and management.
Results
General characteristics of the study population
Socio-demographic characteristics
From a pool of 280 potential participants, 15 were ex-
cluded: five due to a language barrier (natives who could
not understand English), seven due to respiratory
distress and three due to hoarseness of voice. The re-
sponse rate was thus 94.6 %.
Among the 265 patients retained, 136 (51.3 %) were
female. Ages ranged from 21 to 66 years, with mean of
37.0 years (SD: 10.1). The modal age group was 31–40,
representing 38.5 % of the study population. Over half
(52.5 %, n = 139) of the study population was single. The
majority (45.7 %) of the patients had attended secondary
school and 61.5 % of the participants were urban
dwellers. Table 1 summarises the socio-demographic
characteristics of the study population.
Clinical characteristics
A greater proportion (60 %, n = 159) of patients were
outpatients and the majority (77 %, n = 204) were spu-
tum positive TB cases. A large proportion of the partici-
pants (63.8 %, n = 169) were of normal weight (18.5 <
body mass index (BMI) < 25.5Kg/m2). Over half of the
Table 1 Socio-demographic characteristics of adult PTB patients
at the Limbe Regional and Kumba District Hospitals, Southwest
Region of Cameroon, 2015
Variable Description N (%)




Sex Male 129 (48.7)
Female 136 (51.3)












Educational level No school 18 (6.8)
Primary school 112 (42.3)
Secondary school 121 (45.7)
Tertiary 14 (5.3)
Place of residence Urban 162 (61.1)
Rural 102 (38.5)
Living alone Yes 60 (22.6)
No 205 (77.5)
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patients (55.1 %, n = 146) were in the intensive phase
(the first two months) of their treatment. About four-
fifths (80.4 %) were new cases, while the rest were
retreatment cases. Forty-six (17 %) participants reported
to have stopped their treatment at some point; six (2 %)
had stopped less than a month ago, 20 (7.5 %) stopped
between one and two months ago and 20 (7.5 %) had
completely stopped.
With respect to their initial clinical presentations,
nearly half of the patients (n = 124) exhibited less than
four symptoms. The most common symptom was cough
(57.0 %), followed by fatigue (15.4 %), shortness of
breath (10.6 %), fever (9.9 %), weight loss (3 %) and
others (4 %). One hundred participants (37.7 %) had a
co-morbidity, among which 88 (88 %) had HIV/AIDS,
three (3 %) had heart-related diseases, three (3 %) had
asthma and five (5 %) had others, and lastly a case of
chronic obstructive pulmonary disease. Only a quarter
of the patients (25.6 %) reported a family history of men-
tal disease. Table 2 summarises some of the clinical
characteristics of the study population.
Prevalence of depression
The overall prevalence of depressive symptoms in TB
patients was 61.1 % (95 % CI = 55.1–66.8); 103 (38.9 %)
patients had no depression, 97 (36.6 %) had mild depres-
sion and 65 (24.5 %) had moderate depression. Females
were more affected than males (38.5 % vs. 22.6 %). Major
depression was found in 41.5 % (n = 110) of the patients,
with 27.9 % (n = 74) of those female and 13.6 % (n = 36)
male.
Factors associated with depression
Univariate analysis
A cross tabulation using a chi-square test (see Tables 3
and 4) showed a significant relationship between de-
pression and the following variables: sex (P < 0.001),
BMI (P < 0.001), sputum smear type (P < 0.05), treatment
phase (P < 0.05), treatment status (P < 0.05), stopping
treatment before completion (P = 0.001) and time since
stopping (P = 0.001), patient status at time of study
(P = 0.001), those with other co-morbidities (P < 0.001),
with HIV/AIDS being the most common (87.9 %), and
family history of mental illness (P < 0.001).
Multivariate analysis
The multivariable logistic regression analysis showed
that out of the 10 factors investigated (see Table 5), the
following were found to be independently associated
with depression (these patients were more likely to be
depressed): being female (adjusted odd ratio, aOR = 3.0
[1.7–5.5], P < 0.001); on retreatment for PTB (aOR = 11.2
[5.2–31.1], P < 0.001); a family history of mental illness
(aOR = 2.5 [1.3–5.4], P < 0.05); discontinuing treatment
(aOR = 8.2 [1.1–23.3], P = 0.05) and a HIV/TB co-
infection (aOR = 2.5 [1.3–6.5], P < 0.01).
Discussion
Depression is a significant contributor to the GBD and a
major problem for TB patients, leading to non-
adherence of treatment and drug resistance [24]. The
long-term goal of the 2012 World Mental Health Day
was to establish parity for mental health with physical
health in national health priorities and services [3]. Yet
there is still paucity of data on mental health in
Cameroon, with this study being one of the few existing
Table 2 Clinical characteristics of patients with PTB at the
Limbe Regional and Kumba District Hospitals, Southwest Region
of Cameroon, 2015
Variable Description N (%)
Sputum smear at time of diagnosis Positive 204 (77)
Negative 61 (23)
Treatment status New case 213 (80.4)
Retreatment c 52 (19.6)
Treatment phase Intensive 146 (55.1)
Continuation 119 (44.9)
Patient status at time of study Hospitalised 106 (40)
Outpatient 159 (60)
Other co-morbid conditions Yes 100 (37.7)
No 165 (62.3)
TB/HIV co-infection Yes 88 (33.2)
No 177 (66.8)
Family history of mental illness Yes 68 (25.7)
No 197 (64.3)
Table 3 Association of depression and its severity with socio-
demographic variables of patients with PTB in the Southwest
Region of Cameroon, 2015
Variable Severity of depression, N (%) p-value
None Mild Moderate
Sex
Male 69 (53.5) 39 (30.2) 21 (16.3) <0.001
Female 34 (25.0) 58 (42.8) 44 (32.4)
Age
21–30 29 (10.9) 20 (7.5 %) 18 (6.8) <0.001
31–40 38 (14.3) 44 (16.6) 20 (7.5)
41–50 22 (8.3) 14 (5.3) 26 (9.8)
> 51 14 (5.3) 19 (7.2) 1 (0.4)
Living alone
Yes 15 (5.7) 16 (6) 29 (10.9) 0.16
No 88 (33.2) 81 (30.6) 36 (13.6)
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on depression in TB patients, and the first such study
conducted in the Southwest Region of the country.
Prevalence of depression
The prevalence of depression in patients with PTB in
our study was high, with over half (61.1 %) of the
participants affected. This is similar to findings from
India, Iran and Ethiopia, with prevalence rates ran-
ging between 54.2 and 67.1 % [25–27]. Even higher
rates have been reported in Pakistan (72 %), South
Africa (81 %) and India (82 %) [28–30]. However,
slightly lower prevalence rates ranging from 19.2 to
45.5 % have been observed in Ethiopia, Cameroon,
India, Peru and Nigeria [7, 8, 22, 25, 31, 32].
These findings suggest the alarming burden of depres-
sion in TB patients. The high prevalence in our study
may in part be due to the fact that we investigated
depressive symptoms rather than major depressions, as
the other studies have. Secondly, this could also be
accounted for by the high sensitivity and specificity of
the screening tool (PHQ-9) used in our study. Differ-
ences in study settings and patient characteristics could
also partly account for the variation in prevalence rates
for depression across studies. It should be noted, how-
ever, that over a third of TB patients are likely to suffer
from a depressive illness and hence the mental health of
these patients should not be overlooked. Another reason
why this study showed a high prevalence rate may be
Table 4 Association between clinical characteristics and
depression and its severity in patients with PTB in the
Southwest Region of Cameroon, 2015
Variable Severity of depression, N (%) P-value
No depression Mild Moderate
BMI
Underweight 22 (8.3) 22 (8.3) 34 (12.8) <0.001
Normal weight 73 (27.5) 65 (24.5) 31 (47.7)
Overweight 8 (3) 10 (3.8) 0
Sputum smear
Positive 77 (29.1) 69 (26) 58 (21.9) 0.022
Negative 69 (26.0) 28 (10.6) 7 (2.6)
Treatment status
New case 95 (35.8) 78 (29.4) 40 (15.1) 0.016
Retreatment 78 (29.4) 19 (7.2) 25 (9.4)
Stopped treatment before completion
Yes 9 (3.4) 17 (6.4) 20 (7.5) 0.001
No 94 (35.5) 80 (30.2) 45 (17.0)
Patient status
Hospitalised 35 (13.2) 32 (12.1) 39 (14.7) 0.001
Outpatient 68 (25.7) 65 (24.5) 26 (9.8)
Severity of symptoms
No symptoms 23 (8.7) 16 (6.0) 0 0.073
< 4 symptoms 51 (19.2) 55 (20.8) 28 (10.6)
> 4 symptoms 29 (10.9) 26 (9.8) 37 (14)
Co-morbidities
Yes 21 (7.9) 39 (14.7) 40 (15.1) <0.001
No 82 (30.9) 58 (21.9) 25 (9.4)
Family history of mental illness
Yes 15 (5.7) 24 (9.1) 29 (10.9) <0.001
No 88 (33.2) 29 (10.9) 36 (13.6)
Table 5 Multivariable logistic regression analysis showing
factors independently associated with depression in PTB
patients in the Southwest Region of Cameroon, 2015
Variable Multivariate analysis
OR (95 % CI) P-value
Age
> 40 years 1.3 (0.7–2.4) 0.417
≤ 40 years Ref
Sex
Female 3.0 (1.7–5.5) <0.001
Male Ref
Co-morbidity
Yes 2.5 (1.2–6.5) <0.001
No Ref
BMI
< 18.5 kg/m2 0.3 (0.1–1.3) 0.105
18.5–24.9 kg/m 0.4 (0.1–1.4) 0.122
≥ 25 kg/m2 Ref
Treatment phase
Intensive 1.2 (0.6–2.1) 0.723
Continuation Ref
Family history of mental illness
Yes 2.5 (1.3–5.4) 0.013
No Ref
Patient status
Hospitalised 1.2 (0.6–2.3) 0.677
Outpatient Ref
Sputum smear
Positive 1.9 (0.9–3.8) 0.121
Negative Ref
Discontinuation of treatment
Yes 8.2 (1.1–23.3) 0.048
No Ref
Treatment status
Retreatment 11.2 (5.2–31.1) <0.001
New Ref
Kehbila et al. Infectious Diseases of Poverty  (2016) 5:51 Page 5 of 8
the fact that there was a strong association between de-
pression and method of treatment, with 67 % of the hos-
pitalised patients being depressed and the majority
having severe infections. The stigma of isolation, associ-
ation between depression and disease severity, coupled
with a presence of co-morbidities (particularly HIV/TB
co-infection) were probably the drivers of the high
prevalence in this group of patients [33].
Factors associated with depression
An association between depression and sex was ob-
served in our study, with 75 % of females being de-
pressed. This is similar to studies conducted by
Balkissou et al. in Yaoundé, Cameroon, Masumoto et al.
in the Philippines, Aamir and Aisha in Pakistan, and
Panchal and co-workers in India [8, 23, 29, 30]. The pre-
disposition of females could possibly be due to the asso-
ciation between female hormonal factors and depression
[4, 10, 34].
In our study, BMI was a significant factor associated
with depression in PTB patients, with it showing an in-
verse relationship with depression in the bivariate ana-
lysis. Patients with a BMI <18.5 kg/m2 had the highest
level of moderate depression (P < 0.001), which is similar
to a study conducted by Masumoto et al. in Manila,
Philippines (OR 2.16, 95 % CI: 1.25–3.73, P < 0.01) [23].
However, BMI was not a predictive factor of depression
in PTB patients in the multivariable analysis, and hence
the influence of BMI on depression is yet to be
investigated.
Overall, 100 (37.7 %) of the studied TB patients had
an associated chronic illness (87.9 % with HIV/AIDS)
and depression was more frequent (79 %) in patients
with co-morbidities. In fact, patients with a HIV/TB
co-infection where 2.5 times more likely to be de-
pressed than those without (aOR 95%CI = 2.5 [1.2–6.5],
P < 0.001) a co-infection. This is similar to studies done
by Adem et al. in Ethiopia [25], Davoodian et al. in Iran
and Peltzer et al. in South Africa, but unlike in our study,
the latter two found a poor predictive ability in the multi-
variate analysis [27, 28]. This is probably due to the strong
association between HIV and depression, which has been
reported by other studies in our setting [9].
Patients with PTB who have a family history of a men-
tal illness were more likely to be depressed. In our study,
68 (26 %) participants had a positive family history of
mental disorder, with about 77.9 % of them being de-
pressed. The multivariate analysis showed that patients
with a family history of mental illness were 2.5 times
more likely to be depressed as compared to their coun-
terparts. Similar results were obtained in a study con-
ducted in Iran by Davoodian et al. [27]. This finding
could be attributed to the association between genetics
and depression [4, 34, 35], but few studies have
attempted to investigate this relationship with almost
none conducted in our setting.
The prevalence of depression was higher in patients in
the age group of 31–40 years though this association
was not significant in the multivariate analysis. This is
similar to the findings of Masumoto et al. in Manila with
the age group of 31–50 years most affected [23], though
unlike the higher age groups reported in other studies
by Ige et al. in Nigeria, Basu et al. in India, Adem et al.
in Ethiopia and Ugarte-Gil et al. in Peru [7, 21, 25, 32].
The finding in our study is most probably due to the fact
that the majority of participants were youths with a high
prevalence of HIV/TB co-infection. Secondly, our study
was conducted in a predominantly urban setting where
the active and working age group is dominated by
youths due to urbanisation.
Slightly more than half of the study participants were
single (52.5 %), with 59 % of them being depressed. This
was similar to the findings of Basu et al. in India [21].
Unlike our study, other studies have shown a higher
prevalence of depression in partners co-habiting [7], as
well as in divorced couples [29, 30, 36].
No significant relationship was observed between the
level of education and depression in our study (P > 0.05),
even though the prevalence of depression was higher in
those who had never attended school. This is similar to
studies conducted in India by Purohit et al. and in
Pakistan by Aamir and Aisha [26, 29], and could be
accounted in part by the high association between illness
perception of TB and level of depression [33]. Patients
being treated for PTB who had discontinued their treat-
ment at one point and were being retreated, or contin-
ued their treatment had significantly higher odds of
being depressed. Depression may have been the reason
why these patients stopped their treatment in the first
place and the difficulties associated with retreatment
(type of drug and duration of treatment) could make ad-
herence difficult.
Study limitations
This study was cross-sectional by design and could not
establish actual risk factors of depression in TB patients.
There is also the possibility of overestimation of the
prevalence of depression due to the fact that the PHQ-9
contains some symptoms of TB.
We also acknowledge the fact that alcohol and sub-
stance abuse, which are potential factors that have been
associated with depression elsewhere, was not consid-
ered in our study. This is because they are not common
correlates in our setting [9].
Our study is, however, one of the pioneer studies in
Cameroon on depression and TB. The tool used to diag-
nose depression in our study, the PHQ-9, is a standard
screening tool for depressive symptoms, which has
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previously been validated in other settings similar to
ours [37–39], for the diagnosis of depression. Moreover,
the PHQ-9 has high sensitivity and specificity, thus en-
hancing confidence and comparability of our results.
Conclusion
Overall, our findings indicate a high prevalence of depres-
sive symptoms in PTB patients in the Southwest Region of
Cameroon, especially among females, those with a family
history of a mental disorder, those on retreatment for TB,
those who discontinued treatment and those who have a
co-infection with HIV (independent correlates). While
multidisciplinary care is encouraged for this vulnerable
group, larger multicentre cohort studies are warranted to
explore and fine-tune the observations from our study.
Our study not only highlights the need for mental services
in TB units, but also for multidisciplinary and holistic care
for TB patients. Interventions for screening and control of
mental health should be intensified, especially in this vul-
nerable population. We recommend that further studies
are conducted on depression and drug resistance.
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